Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/221924
Title: The interstitial lung disease patient pathway: from referral to diagnosis
Author: Lough, Graham
Abdulqawi, Rayid
Amanda, Gina
Antoniou, Katerina
Azuma, Arata
Baldi, Milind
Bayoumy, Ahmed
Behr, Jürgen
Bendstrup, Elisabeth
Bouros, Demosthenes
Brown, Kevin
Chaudhuri, Nazia
Corte, Tamera J.
Cottin, Vincent
Crestani, Bruno
Flaherty, Kevin R.
Glaspole, Ian
Kawano Dourado, Leticia
Keane, Michael P.
Kolb, Martin
Martínez, Fernando J.
Molina Molina, María
Ojanguren Arranz, Iñigo
Pearmain, Laurence
Raghu, Ganesh
Rottoli, Paola
Stanel, Stefan C.
Tabaj, Gabriela
Vancheri, Carlo
Varela, Brenda
Wang, Bonnie
Wells, Athol
Rivera Ortega, Pilar
Keywords: Malalties del pulmó
Diagnòstic
Pulmonary diseases
Diagnosis
Issue Date: 10-Oct-2024
Publisher: European Respiratory Society (ERS)
Abstract: Background Suspected interstitial lung disease (ILD) patients may be referred to an ILD-specialist centre or a non-ILD-specialist centre for diagnosis and treatment. Early referral and management of patients at ILD-specialist centres has been shown to improve survival and reduce hospitalisations. The COVID-19 pandemic has affected the ILD patient diagnostic pathway and prompted centres to adapt. This study investigates and contrasts ILD patient pathways in ILD-specialist and non-ILD-specialist centres, focusing on referrals, caseloads, diagnostic tools, multi-disciplinary team (MDT) meeting practices and resource accessibility. Methods Conducted as a cross-sectional study, a global self-selecting survey ran from September 2022 to January 2023. Participants included ILD specialists and healthcare professionals (HCPs) from ILDspecialist centres and non-ILD-specialist centres. Results Of 363 unique respondents from 64 countries, 259 were from ILD-specialist centres and 104 from non-ILD-specialist centres. ILD centres had better resource availability, exhibiting higher utilisation of diagnostic tests (median: 12 tests) than non-ILD centres (nine tests) and better access to specialist professions attending MDT meetings (median: six professions at meeting) in specialist centres than nonILD centres (three professions at meeting). Transitioning to virtual MDT meetings allowed HCPs from other locations to join meetings in nearly 90% of all centres, increasing regular participation in 60% of specialist centres and 72% of non-ILD centres. For treatment of patients, specialist centres had better access to antifibrotic drugs (91%) compared to non-ILD centres (60%). Conclusions Diagnostic pathways for ILD patients diverged between specialist centres and non-ILD centres. Disparities in resource and specialist availability existed between centres.
Note: Reproducció del document publicat a: https://doi.org/10.1183/23120541.00899-2024
It is part of: ERJ Open Research, 2024, vol. 11, num. 2
URI: https://hdl.handle.net/2445/221924
Related resource: https://doi.org/10.1183/23120541.00899-2024
ISSN: 2312-0541
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
ERJ Open Res-2025-Lough-00899-2024.pdf1.09 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons